GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...

GSK's regulatory filing for expanded use of RSV vaccine, Arexvy, in adults aged 18 years and older has been accepted for ...

GSK PLC closed 11.51% short of its 52-week high of £16.79, which the company achieved on September 9th.

These findings are very important for patients with early-stage dMMR tumors because it’s likely they do not need surgery or radiation if they are treated first with immunotherapy for a sufficient ...

Nagpur: Tragedy struck a pharma company's unit in Nagpur district on Tuesday when a blast occurred in a glass line reactor, ...

An asthma drug biotech that was acquired in a deal with GSK plc worth up to $1.4 billion is now at the center of a lawsuit, ...

Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds ...

A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy ...

Major global pharmaceutical companies traded lower in the premarket on Tuesday after President Donald Trump reiterated his ...

Twin pipelines will carry liquefied petroleum gas from the country's largest oilfield for conversion into polymers ...

The parents of a 15-year-old boy were arrested for allegedly keeping the boy locked in his room and forcing him to go to the ...